Association Between Body Mass Index and Cognitive Function in Mild Cognitive Impairment Regardless of APOE ε4 Status
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose: In this study we aimed to find the association between neuropsychological performance and body mass index (BMI) in patients with mild cognitive impairment (MCI). In addition, we investigated the effects of the apolipoprotein E (APOE) genotype in the relationship between the BMI and cognition in MCI. Methods: We enrolled a cohort of 3,038 subjects with MCI aged 65–90 from the Clinical Research Center for Dementia of South Korea and a dementia cohort of the Ewha Womans University Mokdong Hospital. MCI patients were classified into three subgroups according to the Asian standard of BMI. We compared cognitive performances between groups by one-way analysis of variance. To investigate the effects of the APOE genotype, we used multivariate linear regression models after adjusting for possible confounders. Results: Even though normal BMI groups were younger, had more females, and had less comorbidities, the higher BMI groups had better cognitive functions. Among subjects with APOE ε4 carriers, there was a positive relationship between the BMI and the memory task alone. Conclusions: Our findings suggested that higher BMI in patients with MCI were associated with better cognitive performance. The effects of the APOE ε4 genotype in the associations between BMI and cognition were distinguishing. Therefore, according to physical status, APOE ε4 genotype-specific strategies in the assessments and treatments may be necessary in elderly patients with MCI.
Abstract
Background and Purpose: In this study we aimed to find the association between neuropsychological performance and body mass index (BMI) in patients with mild cognitive impairment (MCI). In addition, we investigated the effects of the apolipoprotein E (APOE) genotype in the relationship between the BMI and cognition in MCI. Methods: We enrolled a cohort of 3,038 subjects with MCI aged 65–90 from the Clinical Research Center for Dementia of South Korea and a dementia cohort of the Ewha Womans University Mokdong Hospital. MCI patients were classified into three subgroups according to the Asian standard of BMI. We compared cognitive performances between groups by one-way analysis of variance. To investigate the effects of the APOE genotype, we used multivariate linear regression models after adjusting for possible confounders. Results: Even though normal BMI groups were younger, had more females, and had less comorbidities, the higher BMI groups had better cognitive functions. Among subjects with APOE ε4 carriers, there was a positive relationship between the BMI and the memory task alone. Conclusions: Our findings suggested that higher BMI in patients with MCI were associated with better cognitive performance. The effects of the APOE ε4 genotype in the associations between BMI and cognition were distinguishing. Therefore, according to physical status, APOE ε4 genotype-specific strategies in the assessments and treatments may be necessary in elderly patients with MCI.
참고문헌 (52)
- Petersen RC, "Practice guideline update summary : mild cognitive impairment : report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology", Neurology, 90, pp.126~135 (2018)
- Livingston G, "Dementia prevention, intervention, and care", Lancet, 390, pp.2673~2734 (2017)
- Livingston G, "Dementia prevention, intervention, and care : 2020 report of the Lancet Commission", Lancet, 396, pp.413~446 (2020)
- Besser LM, "Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease", Alzheimer Dis Assoc Disord, 28, pp.36~43 (2014)
- Buchman AS, "Change in body mass index and risk of incident Alzheimer disease", Neurology, 65, pp.892~897 (2005)
- Hughes TF, "Association between late-life body mass index and dementia : The Kame Project", Neurology, 72, pp.1741~1746 (2009)
- Pedditzi E, "The risk of overweight", obesity in mid-life and late life for the development of dementia : a systematic review and meta-analysis of longitudinal studies, 2016, pp.45, 14~21
- Power C, "Changes in BMI, duration of overweight and obesity, and glucose metabolism : 45years of follow-up of a birth cohort", Diabetes Care, 34, pp.1986~1991 (2011)
- Atti AR, "Late-life body mass index and dementia incidence : nine-year follow-up data from the Kungsholmen Project", J Am Geriatr Soc, 56, pp.111~116 (2008)
- Fitzpatrick AL, "Midlife and late-life obesity and the risk of dementia : cardiovascular health study", Arch Neurol, 66, pp.336~342 (2009)
- Dekkers IA, "Obesity, brain volume, and white matter microstructure at MRI : a crosssectional UK Biobank study", Radiology, 291, pp.763~771 (2019)
- Hayes JP, "Body mass index is associated with smaller medial temporal lobe volume in those at risk for Alzheimer's disease", Neuroimage Clin, 25, pp.102156~ (2020)
- Zonneveld MH, "Interplay of circulating leptin and obesity in cognition and cerebral volumes in older adults", Peptides, 135, pp.170424~ (2021)
- Doorduijn AS, "Associations of AD biomarkers and cognitive performance with nutritional status : the NUDAD project", Nutrients, 11, pp.1161~ (2019)
- Emmerzaal TL, "2003–2013 : a decade of body mass index, Alzheimer's disease, and dementia", J Alzheimers Dis, 43, pp.739~755 (2015)
- Moser VA, "Obesity and sex interact in the regulation of Alzheimer's disease", Neurosci Biobehav Rev, 67, pp.102~118 (2016)
- Myers RH, "Apolipoprotein E epsilon4association with dementia in a population-based study : The Framingham study", Neurology, 46, pp.673~677 (1996)
- Neu SC, "Apolipoprotein E genotype and sex risk factors for Alzheimer disease : a meta-analysis", JAMA Neurol, 74, pp.1178~1189 (2017)
- Bell SP, "Late-life body mass index, rapid weight loss, apolipoprotein E ε4 and the risk of cognitive decline and incident dementia", J Nutr Health Aging, 21, pp.1259~1267 (2017)
- Kivipelto M, "Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease", Arch Neurol, 62, pp.1556~1560 (2005)
- Ma Y, "Higher risk of dementia in English older individuals who are overweight or obese", Int J Epidemiol, 49, pp.1353~1365 (2020)
- Rahman A, "Sex and gender driven modifiers of Alzheimer's : the role for estrogenic control across age, race, medical, and lifestyle risks", Front Aging Neurosci, 11, pp.315~ (2019)
- 박희경, "Clinical Characteristics of a Nationwide Hospital-based Registry of Mild-to-Moderate Alzheimer’s Disease Patients in Korea: A CREDOS (Clinical Research Center for Dementia of South Korea) Study", Journal of Korean Medical Science, 26(9), pp.1219~1226 (2011), 대한의학회
- Petersen RC, "Mild cognitive impairment as a diagnostic entity", J Intern Med, 256, pp.183~194 (2004)
- Hong YJ, "APOE ε4 allele status in Korean dementia patients with severe white matter hyperintensities", J Alzheimers Dis, 24, pp.519~524 (2011)
- Noh Y, "A new classification system for ischemia using a combination of deep and periventricular white matter hyperintensities", J Stroke Cerebrovasc Dis, 23, pp.636~642 (2014)
- Shiwaku K, "Appropriate BMI for Asian populations", Lancet, 363, pp.1077~ (2004)
- Kang Y, "Seoul Neuropsychological Screening Battery. (SNSBII): Professional Manual" (2012), Human Brain Research and Consulting
- Han C, "An adaptation of the Korean mini-mental state examination(K-MMSE)in elderly Koreans : demographic influence and population-based norms(the AGE study)", Arch Gerontol Geriatr, 47, pp.302~310 (2008)
- Choi SH, "Interchanging scores between clinical dementia rating scale and global deterioration scale", Alzheimer Dis Assoc Disord, 17, pp.98~105 (2003)
- Kim H, "Normative data on the Korean version of the Boston Naming Test", J Clin Exp Neuropsychol, 21, pp.127~133 (1999)
- Doruk H, "The relationship between body mass index and incidental mild cognitive impairment, Alzheimer's disease and vascular dementia in elderly", J Nutr Health Aging, 14, pp.834~838 (2010)
- Rajan KB, "Gene-environment interaction of body mass index and apolipoprotein E ε4 allele on cognitive decline", Alzheimer Dis Assoc Disord, 28, pp.134~140 (2014)
- Joo SH, "Body mass index in mild cognitive impairment according to age, sex, cognitive intervention, and hypertension and risk of progression to Alzheimer's disease", Front Psychiatry, 9, pp.142~ (2018)
- Ye BS, "Unstable body mass index and progression to probable Alzheimer's disease dementia in patients with amnestic mild cognitive impairment", J Alzheimers Dis, 49, pp.483~491 (2016)
- Verhaar BJ, "Nutritional status and structural brain changes in Alzheimer's disease: The NUDAD project", Alzheimers Dement (Amst), 12, pp.e12063~ (2020)
- Anstey KJ, "Body mass index in midlife and late-life as a risk factor for dementia : a meta-analysis of prospective studies", Obes Rev, 12, pp.e426~e437 (2011)
- Suemoto CK, "Body mass index and cognitive function : the potential for reverse causation", Int J Obes, 39, pp.1383~1389 (2015)
- Blautzik J, "Relationship between body mass index, ApoE4 status, and PET-based amyloid and neurodegeneration markers in amyloid-positive subjects with normal cognition or mild cognitive impairment", J Alzheimers Dis, 65, pp.781~791 (2018)
- Sachs-Ericsson NJ, "APOE \xcf\xb54 allele carriers : biological, psychological, and social variables associated with cognitive impairment", Aging Ment Health, 14, pp.679~691 (2010)
- 장재원, "Association of Nutritional Status with Cognitive Stage in the Elderly Korean Population: The Korean Brain Aging Study for the Early Diagnosis and Prediction of Alzheimer’s Disease", Journal of Clinical Neurology, 15(3), pp.292~300 (2019), 대한신경과학회
- Forny-Germano L, "The role of leptin and adiponectin in obesity-associated cognitive decline and Alzheimer's disease", Front Neurosci, 12, pp.1027~ (2019)
- Harvey J, "Leptin and its role in hippocampal synaptic plasticity", Prog Lipid Res, 45, pp.369~378 (2006)
- Sergi G, "Weight loss and Alzheimer's disease : temporal and aetiologic connections", Proc Nutr Soc, 72, pp.160~165 (2013)
- Lourida I, "Association of lifestyle and genetic risk with incidence of dementia", JAMA, 322, pp.430~437 (2019)
- Rosenberg A, "Multidomain interventions to prevent cognitive impairment, Alzheimer's disease, and dementia : from FINGER to world-wide FINGERS", J Prev Alzheimers Dis, 7, pp.29~36 (2020)
- Solomon A, "Effect of the apolipoprotein E genotype on cognitive change during a multidomain lifestyle intervention : a subgroup analysis of a randomized clinical trial", JAMA Neurol, 75, pp.462~470 (2018)
- Liu CC, "Apolipoprotein E and Alzheimer disease : risk, mechanisms and therapy", Nat Rev Neurol, 9, pp.106~118 (2013)
- Corder EH, "Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families", Science, 261, pp.921~923 (1993)
- Kanaya AM, "Total and regional adiposity and cognitive change in older adults : The Health, Aging and Body Composition(ABC)study", Arch Neurol, 66, pp.329~335 (2009)
- Hestad K, "Cognition in patients with memory difficulties and dementia relative to APOE e4 status", Front Psychol, 12, pp.686036~ (2021)
- Rawle MJ, "Apolipoprotein-E(Apoe)ε4 and cognitive decline over the adult life course", Transl Psychiatry, 8, pp.18~ (2018)